Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.39b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Directorate Change

5 Mar 2020 09:21

RNS Number : 1288F
Jardine Matheson Hldgs Ltd
05 March 2020
 

Jardine Matheson Holdings Limited

Directorate Change

 

Jardine Matheson Holdings Limited (the 'Company') announces that, with effect from 15th June 2020, the roles of Executive Chairman and Managing Director, which have been held on a combined basis by Ben Keswick since December 2018, will revert to being separate roles.

 

Ben Keswick will remain as Executive Chairman and John Witt, currently Group Finance Director, will take on the role of Managing Director.

 

John joined Jardines in 1993 and held a range of senior roles across the Group's core businesses and geographies, including as chief financial officer of Hongkong Land and Mandarin Oriental, before being appointed to the Jardine Matheson Board in 2016.

 

John will also be a director of Jardine Strategic Holdings Limited and the Group's listed subsidiaries, Hongkong Land Holdings Limited, Dairy Farm International Holdings Limited and Mandarin Oriental International Limited. He will also continue to be a commissioner of Astra and chairman of the Astra Excom.

 

Graham Baker will replace John as Group Finance Director and will join the Group on 1st June 2020 from Smith + Nephew in the United Kingdom, where he has been a board member and chief financial officer since March 2017. Graham will join the Board of the Company.

 

Prior to joining Smith + Nephew, Graham worked for 20 years for AstraZeneca PLC in a range of senior roles in the UK and internationally, including in Japan and Singapore, and then as chief financial officer of generic pharmaceuticals company Alvogen.

 

Commenting on the changes, Ben Keswick said:

"I am confident that these appointments will strengthen and enhance the effectiveness of the Group's leadership as we respond to the challenges and opportunities we face in positioning Jardines for continuing long term success."

 

- end -

 

For further information please contact

 

Investor enquries:

Jonathan Lloyd

Jardine Matheson Limited

 

(852) 2843 8223

 

Media enquiries:

Brunswick

Tom Burns

 

(44) 207 404 5959

David Ashton

(852) 3512 5063

 

This and other Group announcements can be accessed at www.jardines.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUPUBAWUPUURA
Date   Source Headline
9th Nov 20239:54 amRNSINTERIM MANAGEMENT STATEMENT
9th Nov 20239:52 amRNSINTERIM MANAGEMENT STATEMENT
9th Nov 20239:49 amRNSINTERIM MANAGEMENT STATEMENT
9th Nov 20239:31 amRNSJC&C Interim Management Statement
31st Oct 202311:56 amRNSPT Astra 2023 Third Quarter Financial Statements
31st Oct 202310:03 amRNSTotal Voting Rights
31st Oct 20239:30 amRNSPT HERO SUPERMARKET TBK NINE MONTHS 2023 RESULTS
30th Oct 20239:23 amRNSDirector/PDMR Shareholding
16th Oct 202310:28 amRNSDirector/PDMR Shareholding
13th Oct 202311:32 amRNSDirector/PDMR Shareholding
6th Oct 202310:21 amRNSAdditional Listing
5th Oct 202311:10 amRNSDirector/PDMR Shareholding
3rd Oct 202310:35 amRNSDirector/PDMR Shareholding
29th Sep 202310:45 amRNSTotal Voting Rights
28th Sep 202311:16 amRNSDirector/PDMR Shareholding
27th Sep 202310:26 amRNSDividend
25th Sep 202310:32 amRNSDirector/PDMR Shareholding
25th Sep 202310:31 amRNSBlock listing Interim Review
22nd Sep 202311:29 amRNSDividend
20th Sep 202311:52 amRNSTransaction in Own Shares
14th Sep 202312:58 pmRNSDirector/PDMR Shareholding
12th Sep 202311:47 amRNSTransaction in Own Shares
5th Sep 202312:33 pmRNSTransaction in Own Shares
4th Sep 202311:55 amRNSTransaction in Own Shares
31st Aug 202312:35 pmRNSTotal Voting Rights
31st Aug 202312:29 pmRNSTransaction in Own Shares
31st Aug 202310:37 amRNSPT Hero Supermarket Tbk First Half 2023 Results
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 202310:30 amRNSCirc re. Scrip Dividend Scheme
29th Aug 202311:43 amRNSTransaction in Own Shares
29th Aug 202310:41 amRNSDirector/PDMR Shareholding
29th Aug 20237:44 amRNSTransaction in Own Shares
25th Aug 202311:49 amRNSTransaction in Own Shares
24th Aug 202311:55 amRNSTransaction in Own Shares
23rd Aug 202311:55 amRNSTransaction in Own Shares
22nd Aug 202311:39 amRNSTransaction in Own Shares
21st Aug 202311:23 amRNSTransaction in Own Shares
21st Aug 202310:27 amRNSDirector/PDMR Shareholding
18th Aug 202311:30 amRNSTransaction in Own Shares
18th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 202310:43 amRNSDirector/PDMR Shareholding
14th Aug 202310:40 amRNSDirector/PDMR Shareholding
11th Aug 202310:23 amRNSDirector/PDMR Shareholding
9th Aug 20237:24 amRNSTransaction in Own Shares
8th Aug 20233:27 pmRNSDirector/PDMR Shareholding
7th Aug 202312:19 pmRNSTransaction in Own Shares
2nd Aug 202310:59 amRNSDirector/PDMR Shareholding
1st Aug 20231:37 pmRNSTransaction in Own Shares
28th Jul 20232:03 pmRNSHalf-year Results
28th Jul 20231:48 pmRNSJardine Cycle & Carriage Ltd – Half-year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.